logo

For the Inventor, By the Inventor

Wolhusen, Switzerland

Geistlich Pharma Ag


USPTO Granted Patents = 35

% Expired Patents = 11.4



Trademarks = 13

Forward Citations = 147

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Rolf Wilhelm Pfirrmann (12 out of 48 patents)

silverMedal Michael Alexander Bufler (8 out of 8 patents)

bronzeMedal Lothar Schloesser (6 out of 14 patents)

4.  Claudio Zihlmann (5 out of 5 patents)

5.  Niklaus Stiefel (4 out of 5 patents)

6.  Peter Geistlich (4 out of 27 patents)

7.  Hanns Moehler (4 out of 5 patents)

8.  Thomas Mueller (4 out of 5 patents)

9.  Mark Spilker (3 out of 7 patents)

10.  Daniel Suppiger (3 out of 3 patents)

11.  Paul Buxton (3 out of 3 patents)

12.  Nino Kurz (3 out of 3 patents)

13.  Raphael Kaufmann (3 out of 3 patents)

14.  Charles Zelen (2 out of 2 patents)

15.  David Armstrong (2 out of 2 patents)


35 patents:

1. 12702395 - Applicator of a spongeous collagen membrane and kit comprising such applicator and membrane (2026-08-11),
2. 12534443 - Processes for preparing oxathiazin-like compounds (2026-01-27),
3. 12514847 - Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release (2026-01-06),
4. 11999709 - Processes for preparing oxathiazin-like compounds (2024-06-04),
5. 11633519 - Dried implant composition and injectable aqueous implant formulation (2023-04-25),
6. 11591302 - Processes for preparing oxathiazin-like compounds (2023-02-28),
7. 11571494 - Method for treating subjects suffering from chronic ulcers (2023-02-07),
8. 11357891 - Collagen matrix or granulate blend of bone substitute material (2022-06-14),
9. 11351287 - Bone substitute material (2022-06-07),
10. 10968190 - Processes for preparing oxathiazin-like compounds (2021-04-06),
11. 10960107 - Collagen matrix or granulate blend of bone substitute material (2021-03-30),
12. 10918592 - Injectable aqueous implant formulation containing ascorbic acid (2021-02-16),
13. 10869949 - Method for treating subjects suffering from chronic ulcers (2020-12-22),
14. 10835640 - Resorbable crosslinked form stable membrane for use outside the oral cavity (2020-11-17),
15. 10736902 - Method of treating triple negative breast cancer (2020-08-11),
Geistlich Pharma AG is a leading global provider of medical devices and pharmaceutical products for the healthcare sector. Established in 1851, the company specializes in regenerative medicine and offers innovative solutions for dental, orthopedic, and medical applications. With a strong focus on research and development, Geistlich Pharma AG continues to deliver high-quality products that contribute to patient well-being and improve the quality of life. Visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

35 Patents

#1 in Wolhusen

#396 in Switzerland

#19,119 in the World

Wolhusen, CH
Wolhusen, Switzerland

Geistlich Pharma Ag

Forward Citations = 147

27 inventors:

goldMedal Rolf Wilhelm Pfirrmann (12 out of 48 patents)

silverMedal Michael Alexander Bufler (8 out of 8 patents)

bronzeMedal Lothar Schloesser (6 out of 14 patents)

4.  Claudio Zihlmann (5 out of 5 patents)

5.  Niklaus Stiefel (4 out of 5 patents)

Please report any incorrect information to [email protected]
Loading…